Table 2.
Argentina | Brazil | Chile | |||
---|---|---|---|---|---|
Vaccine in NIP a | MCV-ACWY | MCV-C | MCV-ACWY | MCV-ACWY | 4CMenB |
Age of vaccination | |||||
|
3 and 5 moa | 3 and 5 moa | N/A | N/A | 2 and 4 moa |
|
15 moa | 12–15 moa | N/A | 12 moa | N/A |
|
11 yoa | N/A | 11–12 yoa | N/A | N/A |
Year of implementation | 2017 | 2010/2017 c | 2020 | 2014 | 2023 |
Vaccine uptake (%) b | |||||
|
66.6 | 91 | N/A | N/A | N/A e |
|
54.7 | 84.5 | N/A | 95.6 | N/A |
|
47.5 | 53 d | N/A | N/A |
a NIP: National immunization program. b Vaccine uptake was estimated as median percentage. c Brazil introduced MCV-C for infants and toddlers in 2010. The adolescents were included in 2017 first using MCV-C, followed by MCV-ACWY in 2020. d Includes coverage of both MCV-C and MCV-ACWY during the period. e Data about the uptake of 4CMenB in infants are not available due to its recent implementation. N/A = not applicable (grayed out for better visualization of available data).